Xanadu's stock was a textbook trap that has now sprung, falling about 60% premarket as insiders exit. An S-1 registered about 294M shares for resale by existing holders, which brings the company nothing and floods the float of a startup with $4.6M in annual revenue. A multi-billion-dollar valuation was unsustainable, and as a post-SPAC name its hype premium evaporated once lockups and conversions hit. Brilliant technology doesn't make a safe stock when insiders rush for the exits. x.com 

Xanadu Quantum Technologies' lofty valuation came from linking itself to the hot photonics sector, and in hindsight the push may have been meant to lift the stock as high as possible before selling. A post the author replies to adds that a short float drove the stock far past its fundamental value, and float mechanics did play a role. x.com 

Fluence faces a material short-term overhang after management made about 117.7 million shares eligible for shelf-registered resale. The 20 million-share offering is an unlock and transfer, not dilution, but it leaves roughly 97 million more shares able to be sold, expanding the float and adding selling pressure. That creates a heavy psychological overhang even if nothing is sold; left alone, the stock could easily have doubled. The pending hyperscaler deals are what to watch. x.com  x.com 

C3is is likely to run another round of death-spiral financing once its new shares lift the market cap enough to repeat the process. Class F holders converted and sold zero-cash-exercise shares, getting four for each warrant, so the real conversion price was a fifth of what it appeared, and the company could again find a way to 10x the common share count. Per @ej23ny, the CFO said $48M on hand covers $38M of January payments, with $26M of annual cash generation. x.com  x.com  x.com  x.com  x.com  … Show more